Baker Keith
Direktor/Vorstandsmitglied bei Gyroscope Therapeutics Ltd.
Aktive Positionen von Baker Keith
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Solas Bioventures (mayfield) LLC
Solas Bioventures (mayfield) LLC Investment ManagersFinance Solas BioVentures (mayfield) LLC (Solas BioVentures) is a venture capital firm founded in 2012 by David Adair and Mark Hackett JD. The firm is headquartered in Chattanooga, Tennessee. | Berater | - | - |
Gyroscope Therapeutics Ltd.
Gyroscope Therapeutics Ltd. BiotechnologyHealth Technology Gyroscope Therapeutics Ltd. operates as an ophthalmology firm. It develops a cutting edge, genetically-defined therapies for the treatment of eye diseases linked to an unbalanced complement system. The company was founded on April 18, 2016 and is headquartered in Stevenage, the United Kingdom. | Direktor/Vorstandsmitglied | 01.04.2021 | - |
Eyebiotech Ltd.
Eyebiotech Ltd. BiotechnologyHealth Technology Eyebiotech Ltd. is a British clinical stage ophthalmology company that treats patients with sight-threatening diseases. The company is based in London, UK. Eyebiotech was founded in 2021 by David R. Guyer and Anthony P. Adamis. David R. Guyer has been the CEO since 2021. | Private Equity Investor | 01.01.2023 | - |
Karriereverlauf von Baker Keith
Ausbildung von Baker Keith
Tuck School of Business at Dartmouth | Masters Business Admin |
Geisel School of Medicine | Doctorate Degree |
Duke University | Undergraduate Degree |
Statistik
International
Vereinigte Staaten | 4 |
Vereinigtes Königreich | 3 |
2 |
Operativ
Consultant / Advisor | 1 |
Director/Board Member | 1 |
Masters Business Admin | 1 |
Sektoral
Consumer Services | 4 |
Health Technology | 3 |
Finance | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 3 |
---|---|
Solas Bioventures (mayfield) LLC
Solas Bioventures (mayfield) LLC Investment ManagersFinance Solas BioVentures (mayfield) LLC (Solas BioVentures) is a venture capital firm founded in 2012 by David Adair and Mark Hackett JD. The firm is headquartered in Chattanooga, Tennessee. | Finance |
Gyroscope Therapeutics Ltd.
Gyroscope Therapeutics Ltd. BiotechnologyHealth Technology Gyroscope Therapeutics Ltd. operates as an ophthalmology firm. It develops a cutting edge, genetically-defined therapies for the treatment of eye diseases linked to an unbalanced complement system. The company was founded on April 18, 2016 and is headquartered in Stevenage, the United Kingdom. | Health Technology |
Eyebiotech Ltd.
Eyebiotech Ltd. BiotechnologyHealth Technology Eyebiotech Ltd. is a British clinical stage ophthalmology company that treats patients with sight-threatening diseases. The company is based in London, UK. Eyebiotech was founded in 2021 by David R. Guyer and Anthony P. Adamis. David R. Guyer has been the CEO since 2021. | Health Technology |
- Börse
- Insiders
- Baker Keith
- Erfahrung